BofA/Merrill Lynch Starts Aegerion Pharmaceuticals (AEGR) at Buy
Tweet Send to a FriendGet Alerts AEGR Hot Sheet
Price: $63.70 +2.18%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade AEGR Now!
BofA/Merrill Lynch initiates coverage on Aegerion Pharmaceuticals (NASDAQ: AEGR) with a Buy. PT $39.00.
For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.
Shares of Aegerion Pharmaceuticals closed at $32.52 yesterday, with a 52 week range of $11.75-$32.64.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.
Shares of Aegerion Pharmaceuticals closed at $32.52 yesterday, with a 52 week range of $11.75-$32.64.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Starts Insmed (INSM) at Buy
- Wedbush Starts Intuitive Surgical (ISRG) at Outperform
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
Create E-mail Alert Related Categories
New CoverageRelated Entities
Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
